Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    "retroperitoneal fibrosis"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Methotrexate as a Steroid-sparing Agent in Idiopathic Retroperitoneal Fibrosis: a Randomised, Multicenter Trial
Conditions: Idiopathic Retroperitoneal Fibrosis;   Perianeurysmal Retroperitoneal Fibrosis;   Chronic Periaortitis
Interventions: Drug: Methotrexate+Prednisone;   Drug: Prednisone
2 Unknown  Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis
Condition: Retroperitoneal Fibrosis
Interventions: Drug: Tamoxifen;   Drug: Prednisone
3 Active, not recruiting Rituximab in IgG4-related Disease: A Phase 1-2 Trial
Conditions: Retroperitoneal Fibrosis;   Autoimmune Pancreatitis;   Sialadenitis;   Pseudotumor
Intervention: Drug: Rituximab

Indicates status has not been verified in more than two years